Ellison Rr
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Oncology 4
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 1
-
- Acute Lymphoblastic Leukemia research 4
- Pregnancy and Medication Impact 1
Ellison Rr
9 papers receiving 325 citations
Peers
Comparison fields: 5 of 49
- Hematology 254
- Genetics 58
- Oncology 108
- Public Health, Environmental and Occupational Health 103
- Molecular Biology 133
Countries citing papers authored by Ellison Rr
This map shows the geographic impact of Ellison Rr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellison Rr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellison Rr more than expected).
Fields of papers citing papers by Ellison Rr
This network shows the impact of papers produced by Ellison Rr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellison Rr. The network helps show where Ellison Rr may publish in the future.
Co-authors
The 14 scholars most cited alongside Ellison Rr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. | 1974 | 318 |
| 2 | The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report. | 1960 | 22 |
| 3 | Adriamycin (NSC-123127) in the treatment of acute myelocytic leukemia. | 1972 | 12 |
| 4 | Experience with fluorinated pyrimidines in adenocarcinoma of the lower intestinal tract. | 1962 | 9 |
| 5 | Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. | 1972 | 4 |
| 6 | ADULTS WITH ACUTE LEUKEMIA. | 1964 | 2 |
| 7 | Treatment of chronic granulocytic leukemia with the 6-substituted purines 6-mercaptopurine, thioguanine, and 6-chloropurine. | 1998 | 1 |
| 8 | Management of disseminated neoplastic disease: hematological problems. | 1957 | 1 |
| 9 | CLINICAL PHARMACOLOGIC STUDY OF HADACIDIN (NSC-521778). | 1965 | 1 |
About Ellison Rr
Ellison Rr is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Genetics, Emergency Medicine and Pharmacology, having authored 9 papers that have together received 370 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Lung Cancer Treatments and Mutations (1 paper), Acute Myeloid Leukemia Research (1 paper), Pregnancy and Medication Impact (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Hematology (254 citations), Genetics (58 citations), Oncology (108 citations), Public Health, Environmental and Occupational Health (103 citations) and Molecular Biology (133 citations). Frequent co-authors include Yates Jw, Holland Jf, Wallace Hj, Burchenal Jh, Robert A. Kaufman, Young Cw, Edward Miller, George C. Escher, RN Levy and Todd M. Cooper. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.